Clinical Trials Browser

Phase 2 × tenalisib × Breast × Clear all

NCT05021900 2024-08-13

Efficacy and Safety of Tenalisib (RP6530), in Patients With Locally Advanced or Metastatic Breast Cancer

Phase 2 Completed

40 enrolled 12 charts

Breast Neoplasms